Bottom line
What is RYHIX's expense ratio?
RYHIX's expense ratio is 1.38%, or about $138 a year on every $10,000 invested. That is more expensive than 77% of health care sector funds we track (median 0.96%).
Updated Jul 29, 2026
RYHIX fee table
| Net expense ratio | 1.38% |
|---|---|
| Gross expense ratio | 1.43% |
| Management fee | 0.85% |
| 12b-1 (distribution) fee | 0% |
| Other expenses | 0.58% |
| Fee waiver / reimbursement | -0.05% |
Source: Fund prospectus fee table, filed Jul 29, 2026
What RYHIX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| RYHIX | $140 | $448 | $777 | $1,709 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 1.38% expense ratio costs roughly $73,900 in lost growth, versus about $53,400 for the median health care sector fund (0.96%).
Cheaper alternatives to RYHIX
These funds have a similar portfolio (by top-holdings overlap) and a lower expense ratio. Savings are per $10,000 invested.
*Difference in ending value of $10,000 after 20 years at a 6% gross annual return, net of each fund's expense ratio.